Nov 8, 2018 Assertio Therapeutics Announces Third-Quarter 2018 Financial Results Assertio Therapeutics Announces Third-Quarter 2018 Financial Results“Our third-quarter performance positions us well to achieve our neurology franchise net sales and adjusted EBITDA goals for the full year,” said Arthur ... read morePublished on 2018-11-08